Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer’s disease

Calcitonin gene-related peptide (cGRP) receptor antagonists effectively treat migraine through reducing neuroinflammation, vasoconstriction and possibly neruogenesis. Since neuroinflammation is also involved in the pathogenesis of Alzheimer’s diseases (AD), we hypothesized and tested if a cGRP recep...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuropharmacology
Egile Nagusiak: Na, Hana, Gan, Qini, Mcparland, Liam, Yang, Jack B., Yao, Hongbo, Tian, Hua, Zhang, Zhengrong, Qiu, Wei Qiao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7199095/
https://ncbi.nlm.nih.gov/pubmed/32113968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2020.108017
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak